Status:

COMPLETED

A New Formulation of Intravenous Paracetamol for Fever Management

Lead Sponsor:

Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.

Collaborating Sponsors:

Attikon Hospital

University Hospital of Patras

Conditions:

Fever

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The efficacy of intravenous paracetamol has never been compared with other drugs for the management of fever due to infections. Available data come from clinical studies conducted in healthy volunteer...

Detailed Description

A new formulation of paracetamol for intravenous administration has been manufactured in Greece by the industry Uni-Pharma (ΑPOTEL Μax®). According to this new formulation, 1g of paracetamol is provid...

Eligibility Criteria

Inclusion

  • Written informed consent by the patient
  • Patient of either gender
  • Age equal to or greater than 18 years old
  • Fever onset less than 24 hours
  • Body temperature greater than or equal to 38.50C.
  • Infection of the upper respiratory tract or of the lower respiratory tract or acute pyelonephritis or infection of the skin and soft tissues that can explain fever onset.

Exclusion

  • Age below 18 years old
  • Denial for written consent
  • Intake of paracetamol for any reason either orally or intravenously or intramuscularly the last 12 hours
  • Intake of any non-steroidal anti-inflammatory drug the last 8 hours
  • Intake of any steroidal anti-inflammatory drug the last 12 hours
  • History of liver cirrhosis
  • Serum creatinine greater than 3 mg/dl
  • Aspartate aminotransferase more than 3 times greater than the upper normal limit for the hospital lab
  • Known allergy to non-steroidal anti-inflammatory drugs or to paracetamol
  • Pregnancy or lactation
  • Active bleeding of the upper or the lower gastrointestinal tract
  • Thrombocytopenia defined as any absolute platelet count below 50000/mm3.

Key Trial Info

Start Date :

February 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2016

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT02283203

Start Date

February 1 2015

End Date

March 1 2016

Last Update

March 22 2016

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

General Hospital of Chalkida

Chalcis, Greece, 34100

2

Attikon Hospital

Haidari/Athens, Greece, 12462

3

University Hospital of Crete

Heraklion, Greece, 71110

4

Thriasion Elefsis General Hospital

Magoula Attikis, Greece, 19018